BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 37010807)

  • 21. A C9ORF72 BAC mouse model recapitulates key epigenetic perturbations of ALS/FTD.
    Esanov R; Cabrera GT; Andrade NS; Gendron TF; Brown RH; Benatar M; Wahlestedt C; Mueller C; Zeier Z
    Mol Neurodegener; 2017 Jun; 12(1):46. PubMed ID: 28606110
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Translation of dipeptide repeat proteins in
    Sonobe Y; Lee S; Krishnan G; Gu Y; Kwon DY; Gao FB; Roos RP; Kratsios P
    Elife; 2023 Sep; 12():. PubMed ID: 37675986
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aberrant deposition of stress granule-resident proteins linked to C9orf72-associated TDP-43 proteinopathy.
    Chew J; Cook C; Gendron TF; Jansen-West K; Del Rosso G; Daughrity LM; Castanedes-Casey M; Kurti A; Stankowski JN; Disney MD; Rothstein JD; Dickson DW; Fryer JD; Zhang YJ; Petrucelli L
    Mol Neurodegener; 2019 Feb; 14(1):9. PubMed ID: 30767771
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A mouse model with widespread expression of the C9orf72-linked glycine-arginine dipeptide displays non-lethal ALS/FTD-like phenotypes.
    Verdone BM; Cicardi ME; Wen X; Sriramoji S; Russell K; Markandaiah SS; Jensen BK; Krishnamurthy K; Haeusler AR; Pasinelli P; Trotti D
    Sci Rep; 2022 Apr; 12(1):5644. PubMed ID: 35379876
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence that C9ORF72 Dipeptide Repeat Proteins Associate with U2 snRNP to Cause Mis-splicing in ALS/FTD Patients.
    Yin S; Lopez-Gonzalez R; Kunz RC; Gangopadhyay J; Borufka C; Gygi SP; Gao FB; Reed R
    Cell Rep; 2017 Jun; 19(11):2244-2256. PubMed ID: 28614712
    [TBL] [Abstract][Full Text] [Related]  

  • 26. C9orf72 expansions in frontotemporal dementia and amyotrophic lateral sclerosis.
    Rohrer JD; Isaacs AM; Mizielinska S; Mead S; Lashley T; Wray S; Sidle K; Fratta P; Orrell RW; Hardy J; Holton J; Revesz T; Rossor MN; Warren JD
    Lancet Neurol; 2015 Mar; 14(3):291-301. PubMed ID: 25638642
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A cell-penetrant peptide blocking
    Castelli LM; Lin YH; Sanchez-Martinez A; Gül A; Mohd Imran K; Higginbottom A; Upadhyay SK; Márkus NM; Rua Martins R; Cooper-Knock J; Montmasson C; Cohen R; Walton A; Bauer CS; De Vos KJ; Mead RJ; Azzouz M; Dominguez C; Ferraiuolo L; Shaw PJ; Whitworth AJ; Hautbergue GM
    Sci Transl Med; 2023 Mar; 15(685):eabo3823. PubMed ID: 36857431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. C9orf72 ALS/FTD dipeptide repeat protein levels are reduced by small molecules that inhibit PKA or enhance protein degradation.
    Licata NV; Cristofani R; Salomonsson S; Wilson KM; Kempthorne L; Vaizoglu D; D'Agostino VG; Pollini D; Loffredo R; Pancher M; Adami V; Bellosta P; Ratti A; Viero G; Quattrone A; Isaacs AM; Poletti A; Provenzani A
    EMBO J; 2022 Jan; 41(1):e105026. PubMed ID: 34791698
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Poly(GR) impairs protein translation and stress granule dynamics in C9orf72-associated frontotemporal dementia and amyotrophic lateral sclerosis.
    Zhang YJ; Gendron TF; Ebbert MTW; O'Raw AD; Yue M; Jansen-West K; Zhang X; Prudencio M; Chew J; Cook CN; Daughrity LM; Tong J; Song Y; Pickles SR; Castanedes-Casey M; Kurti A; Rademakers R; Oskarsson B; Dickson DW; Hu W; Gitler AD; Fryer JD; Petrucelli L
    Nat Med; 2018 Aug; 24(8):1136-1142. PubMed ID: 29942091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disruption of ER-mitochondria tethering and signalling in C9orf72-associated amyotrophic lateral sclerosis and frontotemporal dementia.
    Gomez-Suaga P; Mórotz GM; Markovinovic A; Martín-Guerrero SM; Preza E; Arias N; Mayl K; Aabdien A; Gesheva V; Nishimura A; Annibali A; Lee Y; Mitchell JC; Wray S; Shaw C; Noble W; Miller CCJ
    Aging Cell; 2022 Feb; 21(2):e13549. PubMed ID: 35026048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug screen in iPSC-Neurons identifies nucleoside analogs as inhibitors of (G
    Czuppa M; Dhingra A; Zhou Q; Schludi C; König L; Scharf E; Farny D; Dalmia A; Täger J; Castillo-Lizardo M; Katona E; Mori K; Aumer T; Schelter F; Müller M; Carell T; Kalliokoski T; Messinger J; Rizzu P; Heutink P; Edbauer D
    Cell Rep; 2022 Jun; 39(10):110913. PubMed ID: 35675776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of C9orf72 repeat expansions in patients with amyotrophic lateral sclerosis and frontotemporal dementia in mainland China.
    Jiao B; Tang B; Liu X; Yan X; Zhou L; Yang Y; Wang J; Xia K; Shen L
    Neurobiol Aging; 2014 Apr; 35(4):936.e19-22. PubMed ID: 24269022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening for the C9ORF72 repeat expansion in a greek frontotemporal dementia cohort.
    Kartanou C; Karadima G; Koutsis G; Breza M; Papageorgiou SG; Paraskevas GP; Kapaki E; Panas M
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 Feb; 19(1-2):152-154. PubMed ID: 29166782
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The frequency of the C9orf72 expansion in a Brazilian population.
    Cintra VP; Bonadia LC; Andrade HMT; de Albuquerque M; Eusébio MF; de Oliveira DS; Claudino R; Gonçalves MVM; Teixeira AL; de Godoy Rousseff Prado L; de Souza LC; Dourado MET; Oliveira ASB; Tumas V; França MC; Marques W
    Neurobiol Aging; 2018 Jun; 66():179.e1-179.e4. PubMed ID: 29449030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modelling C9ORF72 hexanucleotide repeat expansion in amyotrophic lateral sclerosis and frontotemporal dementia.
    Stepto A; Gallo JM; Shaw CE; Hirth F
    Acta Neuropathol; 2014 Mar; 127(3):377-89. PubMed ID: 24366528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ADAR2 mislocalization and widespread RNA editing aberrations in C9orf72-mediated ALS/FTD.
    Moore S; Alsop E; Lorenzini I; Starr A; Rabichow BE; Mendez E; Levy JL; Burciu C; Reiman R; Chew J; Belzil VV; W Dickson D; Robertson J; Staats KA; Ichida JK; Petrucelli L; Van Keuren-Jensen K; Sattler R
    Acta Neuropathol; 2019 Jul; 138(1):49-65. PubMed ID: 30945056
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dipeptide repeat protein inclusions are rare in the spinal cord and almost absent from motor neurons in C9ORF72 mutant amyotrophic lateral sclerosis and are unlikely to cause their degeneration.
    Gomez-Deza J; Lee YB; Troakes C; Nolan M; Al-Sarraj S; Gallo JM; Shaw CE
    Acta Neuropathol Commun; 2015 Jun; 3():38. PubMed ID: 26108573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell-to-Cell Transmission of Dipeptide Repeat Proteins Linked to C9orf72-ALS/FTD.
    Westergard T; Jensen BK; Wen X; Cai J; Kropf E; Iacovitti L; Pasinelli P; Trotti D
    Cell Rep; 2016 Oct; 17(3):645-652. PubMed ID: 27732842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiogenomics of
    Bonham LW; Geier EG; Sirkis DW; Leong JK; Ramos EM; Wang Q; Karydas A; Lee SE; Sturm VE; Sawyer RP; Friedberg A; Ichida JK; Gitler AD; Sugrue L; Cordingley M; Bee W; Weber E; Kramer JH; Rankin KP; Rosen HJ; Boxer AL; Seeley WW; Ravits J; Miller BL; Yokoyama JS
    J Neurosci; 2023 Jan; 43(2):333-345. PubMed ID: 36446586
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Repeat-associated non-AUG translation in C9orf72-ALS/FTD is driven by neuronal excitation and stress.
    Westergard T; McAvoy K; Russell K; Wen X; Pang Y; Morris B; Pasinelli P; Trotti D; Haeusler A
    EMBO Mol Med; 2019 Feb; 11(2):. PubMed ID: 30617154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.